China–Peru FTA – Origin Cumulation of Pharmaceutical Products

Quelle: https://www.china-peru-fta.gov.cn

The trade agreement between China and Peru allows for the origin cumulation of pharmaceutical products, meaning that materials from both countries can be used together to meet origin rules in order to reduce or eliminate tariffs.

Related Terms

You might also be interested in these terms

China-Peru FTA – Origin Cumulation Toys

The China-Peru Free Trade Agreement allows for the origin cumulation of toys, meaning that products originating in one member country can be considere...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA-Canada FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation refers to the practice wherein the origin of goods in a trade agreement is determined such that products from the EFTA region and Ca...

Learn more

China-Peru FTA – Origin Cumulation Ceramics

Origin cumulation under the China-Peru FTA allows manufacturers to use materials and parts from other FTA partner countries to label their products as...

Learn more